This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO: 62 of Patent CN110785183A
General Information
DRACP ID DRACP06345
Peptide Name SEQ ID NO: 62 of Patent CN110785183A
Sequence LYQEILAQL
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Immunotherapeutic peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target HLA-A*24
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C51H83N11O15
Absent amino acids CDFGHKMNPRSTVW
Common amino acids L
Mass 123318
Pl 3.85
Basic residues 0
Acidic residues 1
Hydrophobic residues 5
Net charge -1
Boman Index 346
Hydrophobicity 65.56
Aliphatic Index 184.44
Half Life
Mammalian: 1.4 hour
Yeast: 3 min
E.coli: >10 hour
Extinction Coefficient cystines 1490
Absorbance 280nm 186.25
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110785183A
Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.